GlassScriptPhysician profile
Eva Kolb
NPI 1750724951
$596.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $542 · 2023: $28.94 · 2024: $25.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $172.36 | 2022 | |
| Lundbeck LLC | $86.18 | 2022-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $82.33 | 2022 | |
| Neurocrine Biosciences, INC. | $46.32 | 2022 | |
| Abbvie INC. | $44.50 | 2022 | |
| Sunovion Pharmaceuticals INC. | $42.69 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $42.44 | 2022 | |
| Tempus Ai, INC | $25.18 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.09 | 2022 | |
| Corium, LLC | $19.68 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Kolb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.